Cargando…
Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells
Treatment of metastasis remains a clinical challenge and the majority of breast cancer-related deaths are the result of drug-resistant metastases. The protein tyrosine phosphatase SHP2 encoded by the proto-oncogene PTPN11 promotes breast cancer progression. Inhibition of SHP2 has been shown to decre...
Autores principales: | Amante, Romain J., Auf der Maur, Priska, Richina, Veronica, Sethi, Atul, Iesmantavicius, Vytautas, Bonenfant, Debora, Aceto, Nicola, Bentires-Alj, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433352/ https://www.ncbi.nlm.nih.gov/pubmed/35739379 http://dx.doi.org/10.1007/s10911-022-09521-x |
Ejemplares similares
-
Targeting Protein-Tyrosine Phosphatases in Breast Cancer
por: Aceto, Nicola, et al.
Publicado: (2012) -
Feed‐forward loops between metastatic cancer cells and their microenvironment—the stage of escalation
por: Baumann, Zora, et al.
Publicado: (2022) -
Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion
por: Aceto, Nicola, et al.
Publicado: (2012) -
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
por: Amante, Romain J., et al.
Publicado: (2023) -
The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?
por: Saint-Laurent, Céline, et al.
Publicado: (2022)